SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
400aaaargh wunder what they got for in the bargain cheers Stefaandalroi-9/22/2003
399Sounds to me as if DYAX isn't going to get royalties on Humira, period. (Unnigel bates-9/22/2003
398Nigel, any idea what they mean by that ? cat/dyax is dyax getting his money frdalroi-9/22/2003
397Cambridge Antibody Technology and Dyax Corp. Further Expand Licensing Agreement nigel bates-9/22/2003
396Cambridge Antibody Technology and Genzyme Corporation Strengthen Collaboration Mnigel bates-9/22/2003
395CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES ANALYSTS SITE VISIT Cambridge, UK... Canigel bates-9/17/2003
394From today's Elan results - <i>* An Investigational New Drug ("Inigel bates-9/17/2003
393This was all that I could find in the listing agreement. Exactly how it is to benigel bates-9/13/2003
392did not read the arbitration agreement if there is one. I did read a newspaper aMadharry-9/12/2003
391Settled IN arbitration or Settled BY arbitration? BTW, have you read the arbitrkeokalani'nui-9/12/2003
390I dont think ABT wants a recurrence of the Roche/Igen fiasco. where it they endeMadharry-9/11/2003
389Just thinking ahead. We’re coming up to the moment ABT has to pay CATG the H rokeokalani'nui-9/11/2003
388Abbott Laboratories Announces European Union Approval of HUMIRA(R) for The Treatnigel bates-9/10/2003
387Two other deals announced today (Micromet & Enzon) - presumably hoping to dinigel bates-9/3/2003
386Cambridge Antibody Technology and Xerion Pharmaceuticals Expand Alliance Into Annigel bates-9/3/2003
385Cambridge Antibody Technology Group plc Announces Financial Results For the Ninenigel bates-9/3/2003
384Bizarrely, this was not announced in the UK - <i>UPDATE - Cambridge Antibnigel bates-8/4/2003
383From the GENZ / SANG announcement - Message 19175886 <i>...Genzyme has senigel bates-8/4/2003
382ROCKVILLE, Md., July 11 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nnigel bates-7/11/2003
381Abbott Laboratories (ABT:NYSE - news - commentary - research - analysis) said sakeokalani'nui-7/10/2003
380MMP inhibitors might be competitors to Trabio (preclinical): Message 19066112 nigel bates-6/27/2003
379Abbott Laboratories Presents New HUMIRA(TM) (adalimumab) Data Showing Effectivennigel bates-6/19/2003
378Cambridge Antibody Technology Reports Completion of Enrollment in European Phasenigel bates-6/17/2003
377ABT is smoking something seriously powerful with this royalty dispute. Here arekeokalani'nui-6/13/2003
376Looks like serono to me.keokalani'nui-6/13/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News